A citation-based method for searching scientific literature

David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry, Suzanne Hill, Roman Jaeschke, Gillian Leng, Alessandro Liberati, Nicola Magrini, James Mason, Philippa Middleton, Jacek Mrukowicz, Dianne O'Connell, Andrew D Oxman, Bob Phillips, Holger J Schünemann, Tessa Tan-Torres Edejer, Helena Varonen, Gunn E Vist, John W Williams, Stephanie Zaza. BMJ 2004
Times Cited: 4498







List of co-cited articles
111 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
23

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
15

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
14

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
10

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
9

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
9

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
8

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
7

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
7

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
6

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
5

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
5

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
5

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
5


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
4

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
4


Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
4

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Penny F Whiting, Anne W S Rutjes, Marie E Westwood, Susan Mallett, Jonathan J Deeks, Johannes B Reitsma, Mariska M G Leeflang, Jonathan A C Sterne, Patrick M M Bossuyt. Ann Intern Med 2011
3

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
3

A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.
Rebecca L Morgan, Kristina A Thayer, Nancy Santesso, Alison C Holloway, Robyn Blain, Sorina E Eftim, Alexandra E Goldstone, Pam Ross, Mohammed Ansari, Elie A Akl,[...]. Environ Int 2019
57
5



The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
3

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
3

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.
Jeffrey C Andrews, Holger J Schünemann, Andrew D Oxman, Kevin Pottie, Joerg J Meerpohl, Pablo Alonso Coello, David Rind, Victor M Montori, Juan Pablo Brito, Susan Norris,[...]. J Clin Epidemiol 2013
586
3

Meta-analysis and subgroups.
Michael Borenstein, Julian P T Higgins. Prev Sci 2013
176
3


The impact of body composition parameters on severe toxicity of nivolumab.
Laure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Audrey Thomas-Schoemann, Julien Kirchgesner, Claire Gervais, Anne Jouinot, Jeanne Chapron, Frédérique Giraud,[...]. Eur J Cancer 2020
15
13

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma.
Louise E Daly, Derek G Power, Áine O'Reilly, Paul Donnellan, Samantha J Cushen, Kathleen O'Sullivan, Maria Twomey, David P Woodlock, Henry P Redmond, Aoife M Ryan. Br J Cancer 2017
95
2

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Valentine Heidelberger, François Goldwasser, Nora Kramkimel, Anne Jouinot, Olivier Huillard, Pascaline Boudou-Rouquette, Johan Chanal, Jennifer Arrondeau, Nathalie Franck, Jérôme Alexandre,[...]. Invest New Drugs 2017
47
4

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
Bolormaa Vandanmagsar, Yun-Hee Youm, Anthony Ravussin, Jose E Galgani, Krisztian Stadler, Randall L Mynatt, Eric Ravussin, Jacqueline M Stephens, Vishwa Deep Dixit. Nat Med 2011
2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
2

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Penny F Whiting, Robert F Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy, Adrian V Hernandez, J Christiaan Keurentjes, Shona Lang, Kate Misso, Steve Ryder,[...]. JAMA 2015
967
2

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins, Martin Eccles, Signe Flottorp, Gordon H Guyatt, David Henry, Suzanne Hill, Alessandro Liberati, Dianne O'Connell, Andrew D Oxman, Bob Phillips,[...]. BMC Health Serv Res 2004
600
2

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
David Moher, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, P J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman. BMJ 2010
2

The GRADE Working Group clarifies the construct of certainty of evidence.
Monica Hultcrantz, David Rind, Elie A Akl, Shaun Treweek, Reem A Mustafa, Alfonso Iorio, Brian S Alper, Joerg J Meerpohl, M Hassan Murad, Mohammed T Ansari,[...]. J Clin Epidemiol 2017
184
2


Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies.
Russell J de Souza, Andrew Mente, Adriana Maroleanu, Adrian I Cozma, Vanessa Ha, Teruko Kishibe, Elizabeth Uleryk, Patrick Budylowski, Holger Schünemann, Joseph Beyene,[...]. BMJ 2015
511
2

Reply to JJ Meerpohl et al.
Lukas Schwingshackl, Sven Knüppel, Carolina Schwedhelm, Georg Hoffmann, Benjamin Missbach, Marta Stelmach-Mardas, Stefan Dietrich, Fabian Eichelmann, Evangelos Kontopantelis, Khalid Iqbal,[...]. Adv Nutr 2017
10
20

Perspective: NutriGrade: A Scoring System to Assess and Judge the Meta-Evidence of Randomized Controlled Trials and Cohort Studies in Nutrition Research.
Lukas Schwingshackl, Sven Knüppel, Carolina Schwedhelm, Georg Hoffmann, Benjamin Missbach, Marta Stelmach-Mardas, Stefan Dietrich, Fabian Eichelmann, Evangelos Kontopantelis, Khalid Iqbal,[...]. Adv Nutr 2016
117
2

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.
Holger J Schünemann, Carlos Cuello, Elie A Akl, Reem A Mustafa, Jörg J Meerpohl, Kris Thayer, Rebecca L Morgan, Gerald Gartlehner, Regina Kunz, S Vittal Katikireddi,[...]. J Clin Epidemiol 2019
173
2

The global burden of low back pain: estimates from the Global Burden of Disease 2010 study.
Damian Hoy, Lyn March, Peter Brooks, Fiona Blyth, Anthony Woolf, Christopher Bain, Gail Williams, Emma Smith, Theo Vos, Jan Barendregt,[...]. Ann Rheum Dis 2014
2

Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.
Nathan I Cherny, Elisabeth G E de Vries, Urania Dafni, Elizabeth Garrett-Mayer, Shannon E McKernin, Martine Piccart, Nicola J Latino, Jean-Yves Douillard, Lowell E Schnipper, Mark R Somerfield,[...]. J Clin Oncol 2019
58
3

Degenerative Meniscus Lesions: An Expert Consensus Statement Using the Modified Delphi Technique.
Erik Hohmann, Richard Angelo, Robert Arciero, Bernard R Bach, Brian Cole, Mark Cote, Jack Farr, Julian Feller, Brad Gelbart, Andreas Gomoll,[...]. Arthroscopy 2020
15
13

National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy.
Mette Jensen Stochkendahl, Per Kjaer, Jan Hartvigsen, Alice Kongsted, Jens Aaboe, Margrethe Andersen, Mikkel Ø Andersen, Gilles Fournier, Betina Højgaard, Martin Bach Jensen,[...]. Eur Spine J 2018
169
2

Research guidelines for the Delphi survey technique.
F Hasson, S Keeney, H McKenna. J Adv Nurs 2000
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.